Postmastectomy Radiation in HER-2 Positive Breast Cancer after Neoadjuvant Therapy: Secondary Analysis of Two Randomized Trials

被引：0
|
作者：
Zeidan, Y. [1 ]
Saifi, O. [2 ]
Bachir, B. [3 ]
Panoff, J. E. [4 ]
Poortmans, P. [5 ]
机构：
[1] Lynn Canc Inst, Baptist Hlth South Florida, Boca Raton, FL USA
[2] Mayo Clin, Dept Radiat Oncol, Jacksonville, FL USA
[3] Amer Univ, Beirut Med Ctr, Beirut, Lebanon
[4] Baptist Hlth South Florida, Miami Canc Inst, Dept Radiat Oncol, Miami, FL USA
[5] lridium Kankernetwerk, Dept Radiat Oncol, Antwerp, Belgium
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2461
引用
收藏
页码：E216 / E216
页数：1
相关论文
共 50 条
  • [41] Patterns of postmastectomy radiation therapy in clinically node-positive breast cancer patients with pathologically negative lymph nodes after neoadjuvant chemotherapy
    Sayan, Mutlay
    Vergalasova, Irina
    George, Mridula
    Kowzun, Maria
    Potdevin, Lindsay
    Kumar, Shicha
    Haffty, Bruce
    Ohri, Nisha
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (02) : 279 - +
  • [42] Survival after neoadjuvant therapy with trastuzumab-lapatinib and chemotherapy in patients with HER2-positive early breast cancer: A meta-analysis of randomised trials
    Guarneri, V.
    Griguolo, G.
    Miglietta, F.
    Conte, P. F.
    Dieci, M. V.
    Girardi, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S407 - S407
  • [43] Omission of Axillary Surgery After Neoadjuvant Therapy in Her2-Positive Breast Cancer: Who Are the Candidates?
    Hamdy, Omar
    Atallah, Khalid
    Elsergany, Alyaa R.
    Atwa, Sara
    Abdo, Rana
    Zaher, Ali
    Abdelhakiem, Mostafa
    CANCERS, 2025, 17 (04)
  • [44] Whole exome analysis of HER-2 positive human breast cancers: molecular mechanisms underlying response to neoadjuvant therapy with trastuzumab
    La Ferla, M.
    Aretini, P.
    Scatena, C.
    Menicagli, M.
    Lessi, F.
    Franceschi, S.
    Cantini, L.
    Bevilacqua, G.
    Naccarato, A. G.
    Fontana, A.
    Mazzanti, C. M.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S191 - S191
  • [45] Whole exome analysis of HER-2 positive human breast cancers: Molecular mechanisms underlying response to neoadjuvant therapy with Trastuzumab
    La Ferla, M.
    Aretini, P.
    Scatena, C.
    Menicagli, M.
    Lessi, F.
    Franceschi, S.
    Cantini, L.
    Bevilacqua, G.
    Naccarato, A. G.
    Fontana, A.
    Mazzanti, C. M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S47 - S47
  • [46] Breast Reconstruction Complications After Postmastectomy Proton Radiation Therapy for Breast Cancer
    Berlin, Eva
    Yegya-Raman, Nikhil
    Hollawell, Casey
    Haertter, Allison
    Fosnot, Joshua
    Rhodes, Sylvia
    Seol, Seung Won
    Gentile, Michelle
    Li, Taoran
    Freedman, Gary M.
    Taunk, Neil K.
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (03)
  • [47] Predictive Biomarker of Response to Neoadjuvant Therapy in HER2 Positive Breast Cancer
    Zhao, Jing
    Meisel, Jane
    Suo, Aili
    Zhang, Chao
    Wei, Zhimin
    Aneja, Ritu
    Li, Zaibo
    Nahta, Rita
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2019, 99
  • [48] Neoadjuvant therapy for triple negative and HER2-positive early breast cancer
    Harbeck, Nadia
    Gluz, Oleg
    BREAST, 2017, 34 : S99 - S103
  • [49] Role of postmastectomy radiation therapy in breast cancer patients according to pathologic nodal status after neoadjuvant chemotherapy
    Kim, Dowook
    Kim, Jin Ho
    Kim, In Ah
    Chang, Ji Hyun
    Shin, Kyung Hwan
    CANCER RESEARCH, 2023, 83 (05)
  • [50] Her-2 Breast Cancer Treatments Induced Variations in the Patterns of Survival and Metastasis in Her-2 Positive Breast Cancers
    McGuire, A.
    Kalinina, O.
    Holian, E.
    Sweeney, K.
    Malone, C.
    McLaughlin, R.
    Lowery, A.
    Brown, J. A. L.
    Kerin, M. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S397 - S397
12345